JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SPRY Financials - Ars Pharmaceuticals Income & Cash Flow | Ledgeburg
SPRY - Ars Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary SPRY Stock
Financials
Financials SPRY Stock
Loading...
Loading...
Income Statement
Income Statement SPRY Stock
Balance Sheet
Balance Sheet SPRY Stock
Cash Flow Statement
Cash Flow Statement SPRY Stock
Loading...
Loading...
Home
Stocks
Ars Pharmaceuticals, Inc. (SPRY)
Financials
Financials of SPRY
Loading...
Loading...
Loading...
Loading...
Revenue
$84.278M
Operating Income
$-179.448M
Net Income
$-171.298M
Share Count (Basic)
98.566481M
Operating Cash Flow
$-170.866M
Free Cash Flow
$-171.205M
Cash And Short-Term Equivalents
$244.986M
Total Debt
$96.374M
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
10M
20M
30M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-150M
-100M
-50M
0
Annual
Quarterly
Margins
Gross
Operating
Net
-200000%
-150000%
-100000%
-50000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-60M
-50M
-40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-500%
-400%
-300%
-200%
-100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26